Fact sheet: Variopartner SICAV SeBiOpp

Fund information

Fund name
Variopartner SICAV Sectoral Biotech Opportunities I USD
Fund company manager
Vontobel Asset Management S.A.
Fund type
SIB
Fund manager
Mina Marmor
since 31/05/2016
Fund objective
While respecting the principle of risk diversification, the Sub-Fund's assets are primarily invested in shares, equity-like transferable securities, participation certificates etc. issued by companies worldwide which are active in the generics sector. No geographical restrictions apply re. specific countries or regions.
Benchmark
Nasdaq Biotech Index
Investment style
None
Investment method
Shares

Quick stats

1 Year return

36.38 %

1 Year rank in sector

1/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 82.6 m

FE Risk score

245

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    75.1%
  • Money Market
    11.6%
  • France
    4.6%
  • Israel
    4.2%
  • Sweden
    2.6%
  • Biotechnology/Medical
    78.2%
  • Money Market
    10.6%
  • Pharmaceuticals
    10.3%
  • Others
    0.9%
  • US Equities
    75.1%
  • Money Market
    11.6%
  • French Equities
    4.6%
  • Israeli Equities
    4.2%
  • Swedish Equities
    2.6%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund10.26 %35.43 %33.93 %0 %0 %
Sector1.98 %12.69 %10.38 %31.15 %105.72 %
Rank within sector1 / 301 / 291 / 29 / /
Quartile th1 st1 st1 st th th

Calendar performance

YTD-20172016201520142013
Fund41.17 %-22.42 %0 %0 %0 %
Sector15.76 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector1 / 2927 / 29 / / /
Quartile th1 st4 th th th th

Price movement

52 week high9.67
52 week low6.48
Current bid price0
Current offer price0
Current mid price9.67

Holdings by region

  • 75.1% USA
  • 11.6% Money Market
  • 4.6% France
  • 4.2% Israel
  • 2.6% Sweden
  • 1% Canada
  • 0.9% Switzerland

Holdings by sector

  • 78.2% Biotechnology/Medical
  • 10.6% Money Market
  • 10.3% Pharmaceuticals
  • 0.9% Others

Holdings by asset type

  • 75.1% US Equities
  • 11.6% Money Market
  • 4.6% French Equities
  • 4.2% Israeli Equities
  • 2.6% Swedish Equities
  • 1% Canadian Equities
  • 0.9% Swiss Equities

Individual holdings

  • 5.8% AMICUS THERAPEUTICS
  • 5.7% NEUROCRINE BIOSCIENCES INC
  • 4.8% ACADIA PHARMACEUTICALS INC
  • 4.3% BIOMARIN PHARMACEUTICAL
  • 4.2% NEURODERM LTD
  • 3.9% AERIE PHARMACEUTICALS INC
  • 3.9% REGENERON PHARMACEUTICALS INC
  • 3.8% SHIRE
  • 3.7% PORTOLA PHARMACEUTICALS INC
  • 3.4% AGIOS PHARMACEUTICALS INC